Integrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathways
Aguirre A. de Cubas(Medical University of South Carolina), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Elena López‐Jiménez(Spanish National Cancer Research Centre), Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Álvaro Gómez Graña, Pilar Ximénez‐Embún(Spanish National Cancer Research Centre), Javier Muñoz(Ikerbasque), Giuseppe Opocher(University of Padua), Francesca Schiavi(Istituto Oncologico Veneto), Cristina Álvarez‐Escolá(Hospital Universitario La Paz), Diego Megı́as(Spanish National Cancer Research Centre), Manuel Pérez‐Martínez(Spanish National Cancer Research Centre), Veronika Mančíková(Centro de Biología Molecular Severo Ochoa), Lucía Inglada‐Pérez(Spanish National Cancer Research Centre), Alberto Cascón(Spanish National Cancer Research Centre), Nuria Ibarz(Spanish National Cancer Research Centre), Iñaki Comino‐Méndez(Breast Cancer Now), Rocío Letón, Agnieszka Maliszewska(Spanish National Cancer Research Centre), Luis J. Leandro‐García(Spanish National Cancer Research Centre)
Cited by 55
Related Papers
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
|Cancer Cell|2017|791
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer
|JAMA Oncology|2019|425